Sunshine Biopharma Inc. Common Stock (SBFM)
Sunshine Biopharma Inc. Common Stock (SBFM) has reported earnings 8 times since May 11, 2023. The stock moves an average of ±6.02% the day after reporting, closing higher 25.0% of the time. Its largest post-earnings gain was +1.35% (May 19, 2025) and its largest decline was -17.26% (May 11, 2023). The next earnings report is predicted for 2026-08-14 (estimated).
Earnings reactions
How SBFM moved on each past earnings report.
Earnings Impact
Total Earnings
8
Avg Abs. Movement
±6.02%
Positive %
25.0%
Negative %
75.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Apr 09, 2026 | ☽ POST | -6.25% | open_in_new |
| May 19, 2025 | ☽ POST | +1.35% | open_in_new |
| Nov 07, 2024 | ☽ POST | -1.47% | open_in_new |
| Aug 19, 2024 | ☽ POST | -1.64% | open_in_new |
Earnings Count
8
Total earnings in dataset
Avg Abs. Movement
±6.02%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 424B5 | 20260720 | open_in_new SEC.gov |
| 8-K | 20260720 | open_in_new SEC.gov |
| 8-K | 20260710 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260708 | open_in_new SEC.gov |
| DEF 14C | 20260608 | open_in_new SEC.gov |
| 8-K | 20260529 | open_in_new SEC.gov |
| PRE 14C | 20260529 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260522 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260521 | open_in_new SEC.gov |
| 424B4 | 20260519 | open_in_new SEC.gov |
Frequently asked about SBFM earnings
When does Sunshine Biopharma Inc. Common Stock report earnings next? expand_more
Sunshine Biopharma Inc. Common Stock (SBFM)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does SBFM stock move after earnings? expand_more
Over 8 reports, SBFM has moved an average of ±6.02% the session after earnings, closing higher 25.0% of the time.
What was SBFM's biggest post-earnings move? expand_more
SBFM's largest post-earnings gain on record was +1.35% on May 19, 2025, and its largest decline was -17.26% on May 11, 2023.
Where can I find Sunshine Biopharma Inc. Common Stock's SEC filings? expand_more
All of Sunshine Biopharma Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right